Association between Refractoriness to 131I Therapy for Differentiated Thyroid Carcinoma and 18F-FDG Accumulation in Lung Metastasis

Maruoka, Yasuhiro; Baba, Shingo; Isoda, Takuro; Kitamura, Yoshihisa; Abe, Koichiro; Sasaki, Masayuki; Honda, Hiroshi

doi:10.21767/2254-6081.100156

Can Res

2017

DOI: 10.21767/2254-6081.100156

|View full text |Cite

Association between Refractoriness to 131I Therapy for Differentiated Thyroid Carcinoma and 18F-FDG Accumulation in Lung Metastasis

Yasuhiro Maruoka¹,

Shingo Baba²,

Takuro Isoda³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 17 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results thus obtained indicated that SUVmax of LM significantly increased in patients without 131I and that this increasing trend was even more severe in case of patients with increased levels of thyroglobulin induced after the administration of 131I. The authors standardized the optimal cutoff value of SUVmax to be 1.6, which can be further implicated for the effective prediction of refractoriness of such patients to the 131I therapy [5].…”

mentioning

confidence: 89%

Editorial Note: Archives in Cancer Research Volume 5, Issue 3

Bidwai¹

2017

Arch Can Res

View full text Add to dashboard Cite

Cancer research implies the methodically planned research studies that intend to elucidate any/all aspects of pathogenic, biochemical, molecular as well as pathological basis of carcinogenesis as well as metastasis of cancer cells. Considering the growing medical burden of cancer on a global scale, it becomes imperative that such studies are conducted, and their findings implemented for the development of newer and better anti-cancer therapeutic regimens. The Archives in Cancer Research journal is specifically intended for the global dissemination of such studies and their findings so that they can help in accentuation of the above described process. The current issue of the journal published many research articles and case reports that serve to enhance the persisting levels of clinical knowledge and skills required for the diagnosis and treatment of cancer.

show abstract

mentioning

confidence: 89%

Editorial Note: Archives in Cancer Research Volume 5, Issue 3

Bidwai¹

2017

Arch Can Res

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Association between Refractoriness to 131I Therapy for Differentiated Thyroid Carcinoma and 18F-FDG Accumulation in Lung Metastasis

Cited by 1 publication

References 17 publications

Editorial Note: Archives in Cancer Research Volume 5, Issue 3

Editorial Note: Archives in Cancer Research Volume 5, Issue 3

Contact Info

Product

Resources

About